Erratum: Comparative Evaluation of 50 Microgram Oral Misoprostol and 25 Microgram Intravaginal Misoprostol for Induction of Labour at Term: A Randomized Trial (Journal of Obstetrics and Gynaecology Canada (2013) 35(5) (408–416)(S1701216315309312)(10.1016/S1701-2163(15)30931-2);Comparative Evaluation of 50 Microgram Oral Misoprostol and 25 Microgram Intravaginal Misoprostol for Induction of Labour at Term: A Randomized Trial

Journal of Obstetrics and Gynaecology Canada

Volumn 35, Issue 5, 2013, Pages 408-416

  Rahman, Hafizur ^a   Pradhan, Anup ^a   Kharka, Latha ^a   Renjhen, Prachi ^b   Kar, Sumit ^a   Dutta, Sudip ^a  

^a SIKKIM MANIPAL INSTITUTE OF MEDICAL SCIENCES   (India)

^b MELAKA MANIPAL MEDICAL COLLEGE   (India)

Author keywords

Cervical ripening; Labour induction; Oral misoprostol; Prostaglandin; Vaginal misoprostol

Indexed keywords

MISOPROSTOL; OXYTOCIN; OXYTOCIC AGENT; PROSTAGLANDIN;

ADULT; APGAR SCORE; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CONTROLLED STUDY; DIARRHEA; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS HEART RATE; FEVER; HUMAN; INSTRUMENTAL DELIVERY; LABOR INDUCTION; MECONIUM ASPIRATION; NAUSEA AND VOMITING; NEWBORN; NEWBORN INTENSIVE CARE; POSTPARTUM HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; UTERINE HYPERSTIMULATION; UTERINE HYPERTONIA; UTERINE TACHYSYSTOLE; UTERUS DISEASE; VAGINAL DELIVERY; CONTROLLED CLINICAL TRIAL; INTRAVAGINAL DRUG ADMINISTRATION; METHODOLOGY; ORAL DRUG ADMINISTRATION; ORAL MISOPROSTOL; TERM BIRTH; TIME; UTERINE CERVIX RIPENING; VAGINAL MISOPROSTOL;

CERVICAL RIPENING; LABOUR INDUCTION; ORAL MISOPROSTOL; PROSTAGLANDIN; VAGINAL MISOPROSTOL;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; FEMALE; HUMANS; LABOR, INDUCED; MISOPROSTOL; OXYTOCICS; TERM BIRTH; TIME FACTORS; YOUNG ADULT;

EID: 84884714964     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jogc.2016.04.094     Document Type: Erratum

References (29)

1. National Institute of Clinical Excellence (NICE) clinical guideline 70. Induction of labour 2008, NICE, London, July.
2. Cheng S., Ming H., Lee J. Titrated oral compared with vaginal misoprostol for labour induction: a randomized controlled trial. Obstet Gynaecol 2008, 111:119-125.
3. Off-label drug use and FDA review of supplemental drug applications: hearing before the subcommittee on Human Resources and intergovernmental relations of the committee on government reform and oversight, House of Representatives, 104th Congress, 2nd session, September 12 1996, 53-94. USGPO, Washington.
4. World Health Organization. Essential medicines: WHO model list (revised March 2005) explanatory notes 2005, March. Available at:, Accessed December 6, 2006. http://whqlibdoc.who.int/hq/2005/a87017_eng.pdf, 14th ed.
5. American College of Obstetricians and Gynecologists New U.S. Food and Drug Administration labeling on Cytotec (misoprostol) use and pregnancy. ACOG Committee Opinion. Number 283, May 2003. Obstet Gynecol 2003, 101(5 Pt 1):1049-1050.
6. Sanchez-Ramos L., Kaunitz A.M., Wears R.L., Delke I., Gaudier F.L. Misoprostol for cervical ripening and labour induction: a meta-analysis. Obstet Gynaecol 1997, 89:633-642.
7. 1 methyl analogue misoprostol versus oxytocin: a randomized trial. Obstet Gynaecol 1993, 81:332-336.
8. Varaklis K., Gumma R., Stubblefield P.G. Randomized controlled trial of vaginal misoprostol and intracervical prostaglandin E2 gel for induction of labour at term. Obstet Gynaecol 1995, 86:541-544.
9. 2 gel for preinduction cervical ripening and labour induction. Am J Obstet Gynaecol 1995, 172:1804-1810.
10. Wing D.A., Rahall A., Jones M.M., Goodwin T.M., Paul R.H. Misoprostol: an effective agent for cervical ripening and labour induction. Am J Obstet Gynaecol 1995, 172:1811-1816.
11. 2 gel (Prepidil gel): randomized comparison. Am J Obstet Gynaecol 1995, 173:1137-1142.
12. Wing D.A., Paul R.H. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labour induction. Am J Obstet Gynaecol 1996, 175:158-164. [erratum in Am J Obstet Gynaecol 1997;176:1423].
13. Kramer R.L., Gilson G.J., Morrison D.S., Martin D., Gonzales J.L., Qualls C.R. A randomized trial of misoprostol and oxytocin for induction of labour: safety and efficacy. Obstet Gynaecol 1997, 89:387-391.
14. Hofmeyr G.J. Misoprostol administered vaginally for cervical ripening and labour induction in the third trimester [Cochrane Review on CD-ROM] 1998, Cochrane Library Update Software, Oxford, England, issue 3.
15. Wing D.A., Paul R.H. Misoprostol for cervical ripening and labour induction: the clinician's perspective and guide to success. Contemp Ob Gyn 1999, 44:46-61.
16. Alfirevic Z., Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev 2006, 2. Issue. Art. No.: CD001338. DOI: 10.1002/14651858.CD001338.pub2.
17. Ngai S.W., To W.K., Lao T., Ho P.C. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term. Obstet Gynaecol 1996, 87:923-926.
18. Windrim R., Bennett K., Mundle W., Young D.C. Oral administration of misoprostol for labour induction: a randomized controlled trial. Obstet Gynaecol 1997, 89:392-397.
19. Bennett K.A., Butt K., Crane J.M.G., Hutchens D., Young D.C. A masked randomized comparison of oral and vaginal administration of misoprostol for labour induction. Obstet Gynaecol 1998, 92:481-486.
20. Shetty A., Danieilian P., Templeton A. A comparison of oral and vaginal misoprostol tablets in induction of labour at term. Br J Obstet Gynaecol 2001, 108:238-243.
21. Seyfettin U., Funda S., Riza M. A comparison of oral and vaginal misoprostol for induction of labour. Eur J Obstet Gynaecol Reprod Biol 2005, 122:57-60.
22. Adair D.C., Weeks J.W., Barrilleaux S., Edwards M., Burlison K. Lewis DF Oral or vaginal misoprostol administration for induction of labour: a randomized double blind trial. Obstet Gynaecol 1998, 92:810-813.
23. Wind D.A., Hamm D., Paul R.H. A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labour induction. Am J Obstet Gynaecol 1999, 180:1155-1160.
24. Zieman M., Fong S.K., Benowitz N.L., Banskter D., Darney P.D. Absorptio kinetics of misoprostol with oral or vaginal administration. Obstet Gynaecol 1997, 90:88-92.
25. Buser D., Mora G., Arias F. A randomized comparison between misoprostol and dinoprostone for cervical ripening and labour induction in patients with unfavourable cervices. Obstet Gynaecol 1997, 89:581-585.
26. Danielian P., Porter B., Ferrie N., Summers J., Templeton A. Misoprostol for induction of labor at term: a more effective agent for induction of labour at term than dinoprostone vaginal gel. Br J Obstet Gynaecol 1999, 10:793-797.
27. Farah L.A., Sanchez-Ramos L., Rosa C., Del Valle G.O., Gaudier F.L., Delke I., et al. Randomized trial of 2 doses of the prostaglandin E1 analogue misoprostol for labor induction. Am J Obstet Gynaecol 1997, 177:364-371.
28. Kolderup L., McLean L., Grullon K., Safford R.N., Kilpatrick S.J. Misoprostol is more efficacious for labour induction than prostaglandin but is it associated with more risk?. Am J Obstet Gynaecol 1999, 180:1543-1547.
29. Paungmora N., Herabutya Y., O-Prasertsawat P., Punyavachira P. Comparison of oral and vaginal misoprostol for induction of labor at term: a randomized controlled trial. J Obstet Gynaecol Res 2004, 30:358-362.